NEPHROPLUS
1 call
Concalls & earnings callsNephrocare Health Services Limited
Every summarised call, newest first. Latest is Q1 FY27, held 12 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →NephroPlus delivered strong Q1 growth with revenue up 23.7% and continued strategic expansion into new cities and countries, driven by its scalable platform model focused on quality, accessibility, and affordability of dialysis care.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹282 Cr | 23.7% | |
| Adjusted EBITDA | ₹65 Cr | 30.7% | |
| Adjusted EBITDA Margin | 23.1% | 120 basis points | |
| Active Guests | 38,262 | 13% |
Latest guidance
- Medium-term growth guidance of 15% to 20% over the next three to five years.
- Intend to open 40 to 50 clinics in India every year.
- Intend to open 10 to 15 clinics in the Philippines every year.
- Aim to add a new international market every 12 to 18 months.
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
NephroPlus delivered strong Q1 growth with revenue up 23.7% and continued strategic expansion into new cities and countries, driven by its scalable platform model focused on quality, accessibility, and affordability of dialysis care.
- Revenue
- ₹282 Cr23.7%
- Adjusted EBITDA
- ₹65 Cr30.7%